Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2025.100766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Yoshitaka Utsumi und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Salivary Gland Neoplasms, Biomarkers, Tumor, Salivary Ducts. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
- Departments of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
- Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
- Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, Tokyo, Japan.
- Department of Otorhinolaryngology, Head & Neck Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Utsumi, Y., Nakaguro, M., Kawakita, D., Hirai, H., Sukeda, A., Kohsaka, S., Tsukahara, K., Hanazawa, T., Kano, S., Yamazaki, K., Ueki, Y., Okami, K., Saito, Y., Ozawa, H., Honma, Y., Shimizu, A., Hanyu, K., Fujii, S., Arai, T., …, & Multi-institutional Joint SDC Study Group in Japan (2025). Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100766
Vancouver
Utsumi Y, Nakaguro M, Kawakita D, Hirai H, Sukeda A, Kohsaka S, et al. Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100766
BibTeX
@article{Utsumi2025,
author = {Utsumi, Yoshitaka and Nakaguro, Masato and Kawakita, Daisuke and Hirai, Hideaki and Sukeda, Aoi and Kohsaka, Shinji and Tsukahara, Kiyoaki and Hanazawa, Toyoyuki and Kano, Satoshi and Yamazaki, Keisuke and Ueki, Yushi and Okami, Kenji and Saito, Yuki and Ozawa, Hiroyuki and Honma, Yoshitaka and Shimizu, Akira and Hanyu, Kenji and Fujii, Shota and Arai, Tomoyuki and Iwaki, Sho and Imaizumi, Sae and Tanaka, Ryoko and Yamauchi, Mayu and Yamamura, Koji and Sekimizu, Mariko and Takahashi, Hideaki and Imanishi, Yorihisa and Sato, Yuichiro and Matsuki, Takashi and Tada, Yuichiro and Nagao, Toshitaka and Multi-institutional Joint SDC Study Group in Japan, Multi-institutional Joint SDC Study Group in Japan},
title = {Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2025.100766}
}
EUVIMED